Brooks Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE650L01011
  • NSEID: BROOKS
  • BSEID: 533543
INR
99.10
-0.6 (-0.6%)
BSENSE

Dec 05

BSE+NSE Vol: 13.05 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Mar'16
Net Sales
48.96
38.73
40.02
35.20
42.71
29.24
41.56
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
48.96
38.73
40.02
35.20
42.71
29.24
41.56
Raw Material Cost
24.04
21.20
22.90
35.66
24.97
14.96
26.39
Purchase of Finished goods
5.41
4.27
4.49
3.66
1.19
2.41
0.00
(Increase) / Decrease In Stocks
0.16
0.04
1.06
-8.42
3.12
-0.56
0.13
Employee Cost
7.60
6.28
5.43
10.94
8.70
3.63
3.90
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
-0.01
-0.01
0.00
0.00
0.00
4.37
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
6.12
5.16
4.41
11.19
9.69
3.45
-0.00
Total Expenditure (Excl Depreciation)
43.32
36.94
38.28
53.03
47.67
23.89
34.78
Operating Profit (PBDIT) excl Other Income
5.64
1.79
1.74
-17.83
-4.96
5.35
6.78
Other Income
0.61
0.27
0.15
0.17
1.26
0.52
0.76
Operating Profit (PBDIT)
6.25
2.06
1.89
-17.66
-3.70
5.87
7.54
Interest
0.58
0.48
0.36
1.25
1.51
0.80
0.46
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.13
Gross Profit (PBDT)
5.67
1.58
1.53
-18.91
-5.21
5.07
7.21
Depreciation
0.78
0.83
0.88
4.26
3.52
1.71
0.59
Profit Before Tax
4.89
0.74
0.65
-23.17
-8.74
3.37
6.61
Tax
0.00
0.00
0.00
-5.63
-2.77
0.00
-0.81
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
4.89
0.74
0.65
-17.54
-5.97
3.37
7.42
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
4.89
0.74
0.65
-17.54
-5.97
3.37
7.42
Share in Profit of Associates
12.67
-7.12
-6.76
0.27
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
5.69
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17.56
-6.38
-6.11
-11.58
-5.97
3.37
0.00
Equity Capital
29.46
26.25
24.70
24.70
24.70
24.70
16.19
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
49.25
62.79
0.00
0.00
0.00
Earnings per share (EPS)
5.96
-2.43
-2.45
-4.69
-2.42
1.36
4.58
Diluted Earnings per share
5.96
-2.43
-2.38
-6.99
-2.44
1.35
0.0
Operating Profit Margin (Excl OI)
11.52%
4.62%
4.35%
-50.65%
-11.61%
18.3%
16.32%
Gross Profit Margin
11.58%
4.08%
3.82%
-53.72%
-12.2%
17.34%
18.45%
PAT Margin
35.87%
-16.47%
-15.27%
-49.06%
-13.98%
11.53%
17.85%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 26.41% vs -3.22% in Sep 2024

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2025 is 375.24% vs -4.42% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 215.08% vs 2.87% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is 20.83% vs 33.33% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Brooks Lab. With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
48.96
69.69
-20.73
-29.75%
Other Operating Income
0.00
0.00
0.00
Total Operating income
48.96
69.69
-20.73
-29.75%
Raw Material Cost
24.04
17.02
7.02
41.25%
Purchase of Finished goods
5.41
10.20
-4.79
-46.96%
(Increase) / Decrease In Stocks
0.16
0.39
-0.23
-58.97%
Employee Cost
7.60
19.45
-11.85
-60.93%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.01
-0.02
-200.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
6.12
21.47
-15.35
-71.50%
Total Expenditure (Excl Depreciation)
43.32
68.54
-25.22
-36.80%
Operating Profit (PBDIT) excl Other Income
5.64
1.15
4.49
390.43%
Other Income
0.61
1.72
-1.11
-64.53%
Operating Profit (PBDIT)
6.25
2.87
3.38
117.77%
Interest
0.58
1.64
-1.06
-64.63%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
5.67
1.23
4.44
360.98%
Depreciation
0.78
4.26
-3.48
-81.69%
Profit Before Tax
4.89
-3.03
7.92
261.39%
Tax
0.00
-0.82
0.82
100.00%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
4.89
-2.22
7.11
320.27%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
4.89
-2.22
7.11
320.27%
Share in Profit of Associates
12.67
0.00
12.67
Minority Interest
0.00
-0.21
0.21
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.56
-2.42
19.98
825.62%
Equity Capital
29.46
35.69
-6.23
-17.46%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
5.96
-0.68
6.64
976.47%
Diluted Earnings per share
5.96
-0.68
6.64
976.47%
Operating Profit Margin (Excl OI)
11.52%
1.65%
0.00
9.87%
Gross Profit Margin
11.58%
1.76%
0.00
9.82%
PAT Margin
35.87%
-3.19%
0.00
39.06%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 48.96 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 26.41% vs -3.22% in Sep 2024

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 17.56 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 375.24% vs -4.42% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.64 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 215.08% vs 2.87% in Sep 2024

Half Yearly - Interest
Interest 0.58 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 20.83% vs 33.33% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.52%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024